These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 35169084)
1. [Diffuse midline glioma]. Saito R No Shinkei Geka; 2022 Jan; 50(1):29-38. PubMed ID: 35169084 [TBL] [Abstract][Full Text] [Related]
2. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367 [TBL] [Abstract][Full Text] [Related]
3. Clinicohistoradiological and surgical outcome in diffuse midline glioma. Kumar Suman A; Bhattacharjee S; Uppin MS; Fathima ST Childs Nerv Syst; 2024 Jan; 40(1):65-71. PubMed ID: 37644138 [TBL] [Abstract][Full Text] [Related]
9. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Castel D; Philippe C; Calmon R; Le Dret L; Truffaux N; Boddaert N; Pagès M; Taylor KR; Saulnier P; Lacroix L; Mackay A; Jones C; Sainte-Rose C; Blauwblomme T; Andreiuolo F; Puget S; Grill J; Varlet P; Debily MA Acta Neuropathol; 2015 Dec; 130(6):815-27. PubMed ID: 26399631 [TBL] [Abstract][Full Text] [Related]
10. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431 [TBL] [Abstract][Full Text] [Related]
11. ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma. Arrillaga-Romany I; Gardner SL; Odia Y; Aguilera D; Allen JE; Batchelor T; Butowski N; Chen C; Cloughesy T; Cluster A; de Groot J; Dixit KS; Graber JJ; Haggiagi AM; Harrison RA; Kheradpour A; Kilburn LB; Kurz SC; Lu G; MacDonald TJ; Mehta M; Melemed AS; Nghiemphu PL; Ramage SC; Shonka N; Sumrall A; Tarapore RS; Taylor L; Umemura Y; Wen PY J Clin Oncol; 2024 May; 42(13):1542-1552. PubMed ID: 38335473 [TBL] [Abstract][Full Text] [Related]
13. Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin. Gilbert AR; Zaky W; Gokden M; Fuller CE; Ocal E; Leeds NE; Fuller GN Pediatr Neurosurg; 2018; 53(1):59-63. PubMed ID: 29131126 [TBL] [Abstract][Full Text] [Related]
14. A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation. Auffret L; Ajlil Y; Tauziède-Espariat A; Kergrohen T; Puiseux C; Riffaud L; Blouin P; Bertozzi AI; Leblond P; Blomgren K; Froelich S; Picca A; Touat M; Sanson M; Beccaria K; Blauwblomme T; Dangouloff-Ros V; Boddaert N; Varlet P; Debily MA; Grill J; Castel D Acta Neuropathol; 2023 Dec; 147(1):2. PubMed ID: 38066305 [TBL] [Abstract][Full Text] [Related]
15. Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location. Karremann M; Gielen GH; Hoffmann M; Wiese M; Colditz N; Warmuth-Metz M; Bison B; Claviez A; van Vuurden DG; von Bueren AO; Gessi M; Kühnle I; Hans VH; Benesch M; Sturm D; Kortmann RD; Waha A; Pietsch T; Kramm CM Neuro Oncol; 2018 Jan; 20(1):123-131. PubMed ID: 29016894 [TBL] [Abstract][Full Text] [Related]
16. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Huang TY; Piunti A; Lulla RR; Qi J; Horbinski CM; Tomita T; James CD; Shilatifard A; Saratsis AM Acta Neuropathol Commun; 2017 Apr; 5(1):28. PubMed ID: 28416018 [TBL] [Abstract][Full Text] [Related]
17. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered? Donev K; Sundararajan V; Johnson D; Balan J; Chambers M; Paulson VA; Scherpelz KP; Abdullaev Z; Quezado M; Cimino PJ; Pratt D; Valerio E; Alves de Castro JV; Carraro DM; Torrezan GT; Wolff BM; Kulikowski LD; Costa FD; Aldape K; Ida CM J Neuropathol Exp Neurol; 2024 Apr; 83(5):357-364. PubMed ID: 38447592 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847 [TBL] [Abstract][Full Text] [Related]
19. A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma. Peng Y; Ren Y; Huang B; Tang J; Jv Y; Mao Q; Liu Y; Lei Y; Zhang Y Sci Rep; 2023 Jun; 13(1):9970. PubMed ID: 37340065 [TBL] [Abstract][Full Text] [Related]
20. H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions. van den Bent M; Saratsis AM; Geurts M; Franceschi E Neuro Oncol; 2024 May; 26(Supplement_2):S110-S124. PubMed ID: 38102230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]